Political support for reforming federal cannabis laws appears to be snowballing: Senate Majority Leader Mitch McConnell, Senate Minority Leader Chuck Schumer, President Donald Trump and former House Speaker John Boehner all recently signaled varying levels of support. In short, a variety of pro-cannabis bills – from hemp legalization and tax reform to granting MJ businesses […]
Read MoreLatest Hemp Industry News
FDA advisory panel gives thumbs-up to CBD epilepsy treatment
A CBD treatment for epilepsy is closer to becoming the first cannabis medicine approved for the U.S. market. A panel of government health advisers gave a unanimous recommendation Thursday to the U.S. Food and Drug Administration to approve Epidiolex, a CBD medicine for rare epilepsy conditions that don’t respond to other drugs. The panel voted […]
Read More
Here’s how the FDA’s review of epilepsy drug could affect CBD companies
It’s shaping up to be a watershed summer for the cannabis industry with the U.S. Food and Drug Administration poised to approve the first drug made from the plant.
The agency’s impending decision on Epidiolex, an epilepsy treatment made of CBD extracted from cannabis flower, could upend decades of government insistence that the plant has no medicinal value.
Read More
Impending ruling on epilepsy drug has CBD industry on alert
The most disruptive product to hit the newly legal hemp industry might be one that will never be sold directly to consumers. GW Pharmaceuticals, a London-based biotech company, is awaiting a final decision from the U.S. Food and Drug Administration to produce the first cannabis-derived treatment to win approval as legal medicine. The decision on […]
Read More
FDA seeks public input on whether cannabis, CBD should be descheduled
As the cannabis plant awaits a high-stakes review from international health authorities, the U.S. Food and Drug Administration (FDA) is asking the public to weigh in on whether cannabis, CBD and other cannabis extracts should be declassified as a controlled substance.
The United Nations’ World Health Organization (WHO) made a preliminary announcement in December that CBD has a low potential for abuse and shouldn’t be scheduled as a controlled substance.
Read More
MJBizDaily launches website dedicated to hemp coverage
As the hemp industry grows in the United States and around the globe, so too does Marijuana Business Daily’s coverage of it. We’ve launched a new website, Hemp Industry Daily, to provide objective and market-driven coverage of where the hemp sector is headed and what business leaders and investors need to know to be successful. […]
Read More
Organa Brands co-founder Ralph Morgan departs for new CBD venture
The co-founder of marijuana vape manufacturer Organa Brands is leaving to start a new company focused on hemp-derived wellness products. Ralph Morgan said he is still exploring a name and headquarters location for his new company, which will produce cannabidiol concentrates marketed to a medical audience, not recreational marijuana consumers. Morgan told Marijuana Business Daily […]
Read MoreConference News
April Issue
Amid growing criticism, NCIA chief Aaron Smith admits missteps and hopes to move the trade group in a new direction.Read the Issue
